Organon To Present at the Piper Sandler 35th Annual Healthcare Conference
November 21 2023 - 7:30AM
Business Wire
Organon (NYSE: OGN), a global healthcare company with a focus on
women’s health, announced today that Kevin Ali, Chief Executive
Officer, and Matthew Walsh, Chief Financial Officer, are scheduled
to participate in a fireside chat at the Piper Sandler 35th Annual
Healthcare Conference on Wednesday, November 29, 2023 at 11:00 a.m.
EST.
Investors, analysts, members of the media and the general public
are invited to listen to a live audio webcast of the presentation
at
https://www.organon.com/investor-relations/events-and-presentations/.
About Organon
Organon is a global healthcare company formed to focus on
improving the health of women throughout their lives. Organon
offers more than 60 medicines and products in women’s health in
addition to a growing biosimilars business and a large franchise of
established medicines across a range of therapeutic areas.
Organon’s existing products produce strong cash flows that support
investments in innovation and future growth opportunities in
women’s health and biosimilars. In addition, Organon is pursuing
opportunities to collaborate with biopharmaceutical innovators
looking to commercialize their products by leveraging its scale and
presence in fast growing international markets.
Organon has a global footprint with significant scale and
geographic reach, world-class commercial capabilities, and
approximately 10,000 employees with headquarters located in Jersey
City, New Jersey.
For more information, visit http://www.organon.com and connect
with us on LinkedIn, Instagram, X (formerly known as Twitter) and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231121549162/en/
Organon Media Contacts:
Karissa Peer (614) 314-8094
Kate Vossen (732) 675-8448
Organon Investor Contacts:
Jennifer Halchak (201) 275-2711
Alex Arzeno (203) 550-3972
Organon (NYSE:OGN)
Historical Stock Chart
From Apr 2024 to May 2024
Organon (NYSE:OGN)
Historical Stock Chart
From May 2023 to May 2024